Flatiron CEO Carolyn Starrett: We’re reimagining the infrastructure of cancer care, and we’re going global
As real-world evidence becomes ever more essential, a cancer health technology company that played a key role in modernizing 21st-century health data is capitalizing on its accomplishments in the U.S.—and moving into international markets to meet the growing demand for actionable data. Founded in 2012, Flatiron Health, now in its…